M&A

Mergers and acquisitions (M&A) are powerful tools for growth, consolidation, and market expansion. At Highway 33 Capital Advisory, we specialize in guiding cannabis companies through the complexities of cannabis mergers and consolidations. Our cannabis M&A advisory services are designed to help businesses maximize their value and achieve long-term success in a highly regulated and volatile market across multiple states.

M&A transactions offer cannabis companies a clear path to growth—whether through expanding market reach, gaining new technologies, or acquiring critical assets. However, the cannabis industry presents unique challenges due to stringent regulations and a rapidly changing landscape. Specialized knowledge is crucial when pursuing cannabis mergers and acquisitions across the USA.

At Highway 33 Capital Advisory, we bring a proven track record in buy- and sell-side mergers and acquisitions, handling deals ranging from $5M to $100M. From buy-side to sell-side deals, our team ensures every transaction is strategically aligned and structured for maximum value.

M&A transactions require specialized expertise, knowledge, and guidance to source the right deal and keep it from collapsing. This is challenging in any industry, but in cannabis—with its regulatory hurdles—experience and well-honed skills are vital.

Our team looks beyond surface-level metrics to determine a prospect’s true value. During our due diligence, we assess critical valuation factors, including:

• Strength of the market of the prospective investment
• Quality of revenue and a path toward sustainable EBITDA
• Quality of business assets
• Compliance with regulations
• Commitment of all parties involved to finalize the deal

We offer a full range of cannabis M&A services to support businesses at every stage of the transaction process:

• Valuation & Due Diligence: We conduct thorough valuations to determine the true worth of a business, ensuring buyers avoid overpaying and sellers avoid undervaluing assets. Our due diligence process examines financial health, asset quality, market position, and regulatory compliance to minimize risks.
• Deal Structuring & Advisory: We assist in structuring the deal to meet your financial and strategic goals, ensuring long-term success and maximizing shareholder value. Our cannabis M&A advisory team works closely with you to identify opportunities that align with your vision.

Regulatory & Market Insights: With extensive knowledge of cannabis regulations across different states, we help clients navigate the legal complexities of cannabis M&A transactions, ensuring compliance and smooth deal execution.

Whether you’re looking to expand through cannabis consolidation, seeking strategic partnerships, or positioning your company for future growth, our services are designed to help you navigate each phase with confidence. We understand that every cannabis company has unique goals, challenges, and opportunities, which is why our approach is tailored to your specific needs.

From startups aiming to scale quickly to established enterprises optimizing their market position in states like Ohio, Connecticut, Illinois, Arizona, New Jersey, Florida, Maryland, Kentucky, or New York, we provide expert advice and strategic guidance to ensure that every deal you pursue is aligned with your long-term vision.

With our deep industry insights and hands-on experience in cannabis mergers and acquisitions across multiple states, we ensure every transaction is structured to drive sustained growth, enhance operational efficiency, and increase value for stakeholders.

In today’s competitive cannabis market, consolidating assets and securing strategic partnerships is key to building a leading brand. Our team understands the dynamics of cannabis consolidation and can help you leverage mergers to strengthen your position, increase efficiency, and drive growth in any state where you operate.

Highway 33 Capital Advisory offers the expertise, resources, and market insights necessary to guide you through every step of the process. Let us help you build leadership brands in industries like biotech, pharma, AgTech, and cannabis, through growth and expansion capital, M&A transactions, and product licensing and distribution agreements.